Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes

Integrated Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes: a Cross-sectional Study Protocol

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this observational study is to better understand how the pancreas works in adults with type 2 diabetes. The study focuses on both hormone production (endocrine function) and digestive function (exocrine function) of the pancreas. The main questions it aims to answer are: * Can problems with the pancreas help identify a different type of diabetes called pancreatogenic diabetes? * How are blood markers and pancreas structure related to pancreatic function? Participants will: * Have blood tests to measure glucose, insulin, and other markers * Provide a stool sample to assess digestive function * Undergo an ultrasound examination of the pancreas * Answer questions about digestive symptoms The study will take place during a single visit in outpatient clinics.

Who May Be Eligible (Plain English)

Who May Qualify: - • adult patients of Kazakh nationality aged 18 to 74 years - diagnosis of T2DM established according to ADA criteria and documented in medical records - disease duration ≤5 years - absence of ketoacidosis episodes within the last 6 months Who Should NOT Join This Trial: - positive anti-glutamic acid decarboxylase antibodies (anti-GAD65); - acute or chronic infections affecting metabolic status within the previous 4 weeks; - any history of malignant neoplasms; - pregnancy or lactation; - previously diagnosed type 1 diabetes mellitus or other specific types of diabetes; - severe decompensated chronic diseases; - conditions associated with systemic fibrosis (e.g., liver cirrhosis or autoimmune conditions (where your immune system attacks your own body)s); - refusal to participate. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * • adult patients of Kazakh nationality aged 18 to 74 years * diagnosis of T2DM established according to ADA criteria and documented in medical records * disease duration ≤5 years * absence of ketoacidosis episodes within the last 6 months Exclusion Criteria: * positive anti-glutamic acid decarboxylase antibodies (anti-GAD65); * acute or chronic infections affecting metabolic status within the previous 4 weeks; * any history of malignant neoplasms; * pregnancy or lactation; * previously diagnosed type 1 diabetes mellitus or other specific types of diabetes; * severe decompensated chronic diseases; * conditions associated with systemic fibrosis (e.g., liver cirrhosis or autoimmune diseases); * refusal to participate.

Locations (1)

Outpatient clinics of Aktobe region, West Kazakhstan Marat Ospanov Medical University
Aktobe, Aktobe Region, Kazakhstan